Prevention of radiocontrast-induced nephropathy.
Baker
Christopher S R
CS
Department of Cardiology, ICSM Hammersmith Hospital, London, U.K. csbaker@blueyonder.co.uk
D003287:Contrast Media / Q000009:adverse effects; D017023:Coronary Angiography / Q000009:adverse effects* / Q000379:methods; D003952:Diagnostic Imaging / Q000009:adverse effects / Q000379:methods; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007677:Kidney Function Tests; D007683:Kidney Tubular Necrosis, Acute / Q000139:chemically induced* / Q000517:prevention & control*; D008297:Male; D011322:Primary Prevention / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D012079:Renal Circulation / Q000502:physiology; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index
D003287:Contrast Media; D019275:Radiopharmaceuticals